Navigation Links
Panel Intelligence Develops Extensive Access to Patient Populations in Oncology
Date:10/6/2009

CAMBRIDGE, Mass., Oct. 6 /PRNewswire/ -- Panel Intelligence, LLC, is pleased to announce expanded capabilities for patient focused market research. For 10 years, Panel Intelligence has provided actionable market intelligence in the form of primary research from clinicians and other healthcare professionals. Panel Intelligence has now significantly expanded its access to patient populations in oncology. This research service provides cancer therapeutics companies with direct access to the ultimate end users of their products and allows them to hear the "voice of the patient."

The range of indications for which Panel Intelligence can now provide patient-based market research includes solid tumor cancers (bladder, breast, colorectal, lung, melanoma, ovarian, prostate, and uterine among others), as well as blood cancers including Hodgkin's and Non-Hodgkin's lymphoma, leukemia (adult ALL, AML, and CML). With this access, Panel Intelligence can recruit statistically robust samples in the cancer types constituting 80% of all cancer illnesses.

With these enhanced patient research capabilities, Panel Intelligence can target patients with defined clinical conditions and parameters to allow segmentation into specific subpopulations by clinical and demographic data. Panel Intelligence accesses a database that includes a profile of each patient and specifically defines their treatment history. As a result, our clients can obtain market research from the specific patient population they are targeting. This service enables clients to evaluate patient education materials, understand compliance issues, and determine unmet needs.

"We are now confident in saying that for almost any patient-focused qualitative or quantitative market research assignment, including tracking surveys and ongoing patient panels, Panel Intelligence can deliver fast, highly targeted, and reliable research reflecting the voice of the patient. We have executed many such assignments and are excited to provide an additional value added service to the life science industry," said Janet Bernard, Vice President for Community at Panel Intelligence.

About Panel Intelligence

Panel Intelligence, LLC, based in Cambridge, Mass., provides primary market research to corporate and financial clients in the healthcare industry. Our seasoned research staff understands the unique complexities of each industry, as well as the types of decisions our clients need to support. As a research partner, we work closely with our clients to identify objectives, recruit experts, elicit information, and synthesize results. Our domain expertise, global network of experts, and proven online methods all combine to help our clients make better decisions.

    Contact at Panel Intelligence:
    Howard Brick
    Chief Operating Officer
    Howard.brick@panelintelligence.com
    617-532-5710

To see press release go to http://myprgenie.com/2648

SOURCE Panel Intelligence, LLC


'/>"/>
SOURCE Panel Intelligence, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Expert Panel of Pediatric Liver Specialists Publishes Recommendations for Monitoring and Referral of Children With Chronic Hepatitis B Infections
2. Oracle OpenWorld 2009 Panel to Feature Two Experts from National Healthcare Leadership Organizations -- the FDA and GS1 Healthcare US -- with Loftware and Oracle Representatives
3. Elaine Alquist, Willie Brown and Kim Belshe Convene Purple Ribbon Panel, Task Force on Alzheimers
4. Death Panel Inventor & Critic of Healthcare Reform Betsy McCaughey Has Close Ties to Philip Morris; Healthcare Industry Today Offers Complete Coverage
5. InfoLogix to Present Mobile in the Enterprise: Keeping up with User Demand While Containing Costs at Mobile Monday Panel in Philadelphia
6. Allied Worlds Nicole Baummer to Speak on Panel at National Employment Practices Liability Insurance ExecuSummit
7. Siperian to Host Webinar With Panel of Pharmaceutical Experts
8. FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males
9. FDA Panel Weighs Approving HPV Vaccine for Males
10. Cepheid Announces Accelerated Development of Flu A Panel Test
11. Arbitration Panel Finds in Favor of Tennessee Victim of Mariner Nursing Home Negligence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... ... program owned and organized by HMP Communications Holdings, LLC, today announced that ... within its nationwide network of wound centers interested in becoming Certified Wound Specialist ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... solutions, today named The Resource Group as their 2016 Microsoft Dynamics Partner of ... in Newport Beach, CA. The award recognizes The Resource Group for their ...
(Date:3/23/2017)... Boca Raton, FL (PRWEB) , ... March 23, ... ... range of dietary supplements that help improve all aspects of people’s health and ... popular website for nutritional products. , Natural Subsistence develops nutritional supplements that ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... with all Americans facing life-altering and fatal diseases in opposition to the ... decisions that would eviscerate care, services, and hope for the most vulnerable among ...
(Date:3/23/2017)... Rey, CA (PRWEB) , ... March 23, 2017 ... ... its customizable coding audit software solution, iCode Assurance, at HCCA’s 21st annual Compliance ... optimizes and accelerates the coding audit process for all medical chart types with ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... Denmark , March 23, 2017 Ascendis ... its innovative TransCon technology to address significant unmet medical ... will host a conference call and webcast on Monday, ... the Endocrine Society in Orlando, Florida ... disease pipeline candidates (TransCon Growth Hormone, TransCon PTH and ...
(Date:3/23/2017)... 2017  Cornerstone Pharmaceuticals, Inc., a clinical-stage, ... today.  Following successful End-of-Phase I (EOP1) Type ... Drug Administration (FDA), the Company has been ... forward to conduct pivotal trials of its ... myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... AVIV, Israel , March 23, 2017 ... on oncology and immunology, announced today that it has acquired ... immunotherapy platform. Acquisition consideration consisted of a $6 million upfront ... remainder in BioLineRx shares. Additional future payments may be made ... ...
Breaking Medicine Technology: